chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021 at 1:45 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Nov-2021 at 1:45 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient age was reported as 67.23 No concomitant medications were reported. The vial underwent temperature excursion on 03-Nov-2021 with temperature 35 degrees Fahrenheit and the vial was initially moved to the fridge on 05-Oct-2021 and proposed beyond use date was 05-Nov-2021. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. No treatment information was provided.
Vaccine was placed in refrigerator on 22-Sep-2021 with expiry date on 03-Oct-2021 administered on 29-Nov-2021.; Dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was placed in refrigerator on 22-Sep-2021 with expiry date on 03-Oct-2021 administered on 29-Nov-2021.) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was placed in refrigerator on 22-Sep-2021 with expiry date on 03-Oct-2021 administered on 29-Nov-2021.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was placed in refrigerator on 22-Sep-2021 with expiry date on 03-Oct-2021 administered on 29-Nov-2021.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. It was reported that, there was a confusion between the expiration date printed in the carton the expiration date when the QR code was scanned. The vial was initially refrigerated on 22-Sep-2021, the vial did not undergo any temperature excursion and patient did not experience any adverse events. No treatment medication information was provided.
Pressure throughout body; cold; tired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Pressure throughout body), NASOPHARYNGITIS (cold) and FATIGUE (tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DISCOMFORT (Pressure throughout body), NASOPHARYNGITIS (cold) and FATIGUE (tired). At the time of the report, DISCOMFORT (Pressure throughout body), NASOPHARYNGITIS (cold) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       NO CONCOMITANT AND TREATMENT DRUGS WERE USED
covid vaccine make it hard to breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (covid vaccine make it hard to breath) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (covid vaccine make it hard to breath). At the time of the report, DYSPNOEA (covid vaccine make it hard to breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.   Reporter did not allow further contact
shortness of breath Narrative: Patient received his 1st COVID vaccine on 1/13/21. Two days later he noted increasing shortness of breath, which worsened over the next 2 days resulting in an ED visit on 1/17/21. No fever, head congestion, N/V or diarrhea. O2 sat 93-94%. Venous blood gas unremarkable. Treated with Solumedrol x 1, Duoneb x 2 and discharged from ED to home with prednisone x 4 days and doxycycline x 7 days.
Admitted to hospital with increasing weakness and inability to get out of a chair. Also reports increased cough and fatigue. Treatment includes supplemental oxygen, remdesivir, and therapy.
there was a child who received the second dose of GARDASIL 9 vaccine and had to be rushed to Hospital in and later died; there was a child who received the second dose of GARDASIL 9 vaccine and had to be rushed to Hospital; This spontaneous report was received from a physician and his wife via a field represent, referring to a child of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were unknown.  On an unknown date, the patient received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (strength, dose, route, lot# and expiration date were not reported) vaccine for prophylaxis.   On an unknown date, the patient had to be rushed to hospital (ill-defined disorder) and later died. It was unknown if an autopsy was performed. Furthermore, it was unknown if the patient had sought medical attention, laboratory diagnostic studies were performed or if received any treatment. The outcome of ill-defined disorder was unknown. The causality assessment was not reported.
As in the past following a round of DTAP vaccination, my son broke out following his 5/14/18 DTAP vaccination, which started as an injection site reaction with red raised patches and bruising. The rash mutated each day and eventually covered his right lower abdomen and the entire right thigh.  The rash slowly spread to other body parts including the face and cheeks. This dry, red raised rash would begin as bumps and then would become less bumpy and appear to turn into a contact dermatitis. Insert of vaccine clearly states that certain ingredients in DTAP (including neomycin) can present as anaphylaxis or contact dermatitis. My son has had this rash since the date of the DTAP vaccine and is still struggling from the red bumps as of today (7/7/18). Urgent care unable to identify rash as well. No changes in environmental condition besides vaccination. My son has also shown similar full-body reactions of red dots and bumps (sometimes with fevers) following each one of this DTAP shots (which was initially thought to be a reaction to an antibiotic). Other adverse events stemming from DTAP vaccination in combination with other scheduled vaccines are bronchiolitis (needing a nebulizer), chronic ear infections (stated on insert as a side effect), which led to antibiotic overuse.
This spontaneous report as received from a pharmacist refers to a patient of unknown age (gender not reported). Pertinent medical history, drug reactions or allergies were not reported. On 19-JUL-2014 the patient was vaccinated with improperly stored dose of ZOSTAVAX, lot number: J011548, expiration date: 19-DEC-2014, (dose, route not reported). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
It started out that I could not breath and I was coughing really bad. I thought it was bronchitis. I contacted my doctor, but she was out of town. I was seen by the nurse. She gave me 2 COVID-19 tests, negative results. I called on Saturday October 30th because I was not feeling any better. She gave me a prescription to help. I have been in the house all week. These symptoms have been going on for about a week since it got really bad.
Pt received vaccinations on 8/27/02 at approx. 1520 swelling was noticed by mother on the left deltoid on 8/28/02 at 1330. She administered Tylenol and applied. There no other s/sx of a reaction. No SOB itching or generalized rash. Swelling increased by 1600 on 8/29/02 and pt was brought into health dept. take evaluation. On 8/30/02 mother reports swelling disappeared and pt feeling fine.
Patient contacted us to  report having muscle spasms in her left thigh post vaccination. Vaccinated in left arm. She states that she never has had these spasms in past and these developed 24 hours after receiving vaccination so did not know if related or not. Has not injured leg in question. No other symptoms noted. Still having spasms at time reported today.
PT HAS RECEIVED SIX DOSES OF HEP B VACCINE(S) (MAY BE ENGERIX-B), AND HAS NOT PRODUCED ANTIBODY.
About 10 minutes after administration of Pfizer vaccine, patient started feeling shortness of breath and was hyperventilating. Her face was red and her eyes were swollen. Patient was administered Epipen 0.3mg in her right deltoid. Patient was driven by family member to Hospital to treat allergic reaction since it is 2 blocks away.
uncontrollable laughing and crying, nausea and vomiting especially when standing, feeling of going to pass out and lightheadedness, very red, swollen, and flushed face and ears, eyes were droopy, barely had feeling in face and had a hard time moving jaw. Extreme back pain and facial pain, feeling of shakiness, face turned white like was going to vomit or pass out. Very cold feeling all over but was drenched in sweat. Very tired.
Around 7:45 pm  5/5 after getting the vaccine about 9:08 am 5/5 I started to get light headed, head pounding and nauseous. My entire body ached and I was freezing. I could hardly open a water bottle do to severe weakness throughout my body which i've never had trouble with opening things.  Throughout the night I had chills and  then was hot then freezing and back and fourth. I tried to get up towards the morning a couple times and was extremely dizzy, weak, and nauseous. I started to have ringing in my ears and everything went black. I was able to lay down before passing out. Throughout the day 5/6 until about 5:00pm I couldn't move without  getting very dizzy and nauseous and starting to lose hearing and vision. My heart beat on my fitbit was also tracking about 10 bpm faster than normal. Today 5/7 I am tired and still consistently nauseous throughout the day.
24hr post vax (MMR) pt devel rash to trunk that spread all over body;rash is a circular wheat w/a pale center becoming erythematous to outer border;no resp compromise;
Shingles outbreak emerged about 72 hours after vaccine.  Prescribed Acyclovir 800mg on 12/22/2020 Also had a co-worker develop shingles within 24 hours of the vaccine this week.
PFIZER/BIONTECH 0.3ML FOR IM LOT EN6205 EPX:06/30/2021 No known adverse events.  Vaccinated under FDA approved age.
Skin reaction 6 mm erythematous & indurated macule/patch at injection site > 2 weeks.
Patient reported swelling of his tongue. This started the day after the vaccine and lasted approximately 2 weeks. Patient has not had this reaction with past flu vaccines. Patient did not seek any medical treatment or followup; only just mentioned today in pharmacy. Patient is aware of report. Please contact patient for further information.
I was having a sore throat in the afternoon which lasted for a couple of days. Then I had a sore throat and nasal congestion. On Monday I went to the doctor, and it was diagnosed as an upper respiratory viral infection. The cough was horrible, and I was fatigued. I went back to the doctor the next week and was told the same thing. I then was diagnosed as having pneumonia and this was still lingering, and I thought it might be a sinus infection, but it was still just the chest cold, and it took four weeks for me to not feel sick.
Approximately 3 months after my 3rd shot (Booster) I experienced the following symptoms: Swollen lymph nodes all over my body, Abdominal swelling. I did not take anything for treatment and I went to see a doctor to figure out what's happening. My doctor said he thinks I have lymphoma but it's not an official diagnosis yet. I had several blood tests and scheduled to get a biopsy soon. Somehow it does affect my daily activities and I feel fatigued for the most part.
The mother of a 2 month old male reported that her son received his first dose of Rota Shield, as well as Hib, DtaP and IPV vaccines on 8/25/99. Within a "few" days, the infant developed "runny stools". He also developed constipation for 4 days, however the runny stools continued. The mother notified the MD, no treatment was prescribed.
Patient reported swollen upper right arm with 2 large knots, injection site hot to the touch, and a sore neck. No fever. Symptoms began 2 days after receiving vaccination. All symptoms had resolved after an additional 2 days. Patient also received influenza vaccination in the left deltoid, but reported no adverse reactions at the site.
Patient was admitted to the hospital from a skilled nursing facility with asymptomatic COVID-19 on 6/20/2021, subsequent to receipt of a full series of COVID-19 vaccines
Bell's palsy; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 28Apr2021 16:45 (Batch/Lot Number: EWO172) as 1st dose, single for covid-19 immunisation in Pharmacy or Drug Store. Medical history included myocardial ischaemia/Ischemic heart disease. Concomitant medication included acetylsalicylic acid (ASPIRINE) received within 2 weeks of vaccination. the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No Past drug event. The patient experienced bell's palsy on 13May2021 13:00. Hospitalization Prolonged was No. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19 included RT PCR SARS COV 2 on 09May2021: negative with Nasal Swab. treatment received for the adverse event included Corticosteroids, naproxen. Outcome of the event was recovering.   Follow up needed, further information has been requested.
Itchy, swollen, partially red, and raised area around injection site, noticed 10 days after injection. No pus, drainage, or broken skin. Red area approx 1.5" diameter. Symptoms mild as of completion of this form, I am submitting the form because I had only heard of this delayed reaction spoken of for the Moderna vaccine, whereas I had the Pfizer vaccine. I had had some arm soreness onset about 6 hours or so after I received the vaccine, but I had not noticed this continuing red spot until today.
This spontaneous case was reported by a consumer and describes the occurrence of DRUG INTERACTION (she was advised to use antibiotics for some reason. Interaction between the vaccine and antibiotics), FEELING ABNORMAL (did not feel good), CHILLS (Shivering) and MYALGIA (pain in her muscles) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039DZIA) for COVID-19 vaccination. No Medical History information was reported.On 26-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced FEELING ABNORMAL (did not feel good), CHILLS (Shivering) and MYALGIA (pain in her muscles). In November 2021, the patient experienced DRUG INTERACTION (she was advised to use antibiotics for some reason. Interaction between the vaccine and antibiotics). At the time of the report, DRUG INTERACTION (she was advised to use antibiotics for some reason. Interaction between the vaccine and antibiotics), FEELING ABNORMAL (did not feel good), CHILLS (Shivering) and MYALGIA (pain in her muscles) outcome was unknown. Treatment medications include Antibiotics.No concomitant medications were provided.Most recent FOLLOW-UP information incorporated above includes:On 16-Nov-2021: Non-Significant Follow up appended on 16-11-2021 contains.
Underage before the approval for Pfizer vaccine  Suspected falsification of DOB ? guardian ?unsure? how DOB error occurred
kidney function was low; Blood sugar was upto 950; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERGLYCAEMIA (Blood sugar was upto 950) and RENAL IMPAIRMENT (her kidney function was low) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concurrent medical conditions included Kidney absent.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced HYPERGLYCAEMIA (Blood sugar was upto 950) (seriousness criterion hospitalization). On 11-Mar-2021, the patient experienced RENAL IMPAIRMENT (her kidney function was low) (seriousness criterion hospitalization). The patient was hospitalized from 11-Mar-2021 to 14-Mar-2021 due to HYPERGLYCAEMIA and RENAL IMPAIRMENT. At the time of the report, HYPERGLYCAEMIA (Blood sugar was upto 950) and RENAL IMPAIRMENT (her kidney function was low) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Blood glucose: 950. On 09-Mar-2021, Renal function test:. On 11-Mar-2021, Renal function test: Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was back on insulin after two years of being off insulin. Concomitant medications were not reported.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
1600 reported petechiae to both upper arms and abdomen  1611  took 25 mg bendryl  waiting for 15 min. didn't get any worse  went home
Started with throat discomfort and problems with eating since the vaccine. 3 days of tiredness and headache. Days 5-7 severe allergy all over body and fever.
I received my Moderna booster on 11/13/2021 at about 3PM. On 11/14/2021 at about 9AM, I awoke with muscle pain in the upper body, as well as joint pain and stiffness that were also primarily in the upper body. I took a full dose of oxycontin and oxycodone, but they helped the pain only slightly. The pain was so intense that standing, bending, reaching, and turning my head were very difficult. My husband had to help me with basic tasks, such as dressing myself, retrieving items from cabinets, and getting into my vehicle. I was also unable to drive. I was unable to roll over in bed, and I couldn't sit up in bed without using a side rail to pull myself up. On top of all that, I also had a fever of 101.4. Aside from the fever, all of my symptoms continued on 11/15/2021. I then felt mildly better on 11/16/2021 and 11/17/2021, as the stiffness, joint pain, and muscle pain were less pronounced. Then on 11/18/2021, the pain returned to its previous intensity. It ranged between a 6 and 7 on a 1-10 scale. Oxycontin and oxycodone reduced the pain to a 4 or 5. I also began to have more pain in the lower back, hips, and thighs. On 12/10/2021, I underwent lab tests that included bloodwork for ESR, CRP, aldolase, ammonia levels, and CBC with differential were done. I also underwent a comprehensive metabolic panel and a prothrombin time test. When I got my test results on 12/18/2021, I learned my ESR levels were 43, but my CRP and aldolase levels were normal. The rest of the tests were also within my normal range. I was given a 5-day supply of 20 mg of prednisone. By 12/20/2021, I finally experienced some relief. When I saw my internist on 12/20/2021, I was diagnosed with polymyalgia rheumatica. She told me to continue taking 20 mg of prednisone daily and to return in about 4 weeks for follow-up tests and an office visit.
79 pts recv vax; 3 pt exp irritability; 24 exp apnea w/bradycardia & O2 desaturation-tx=oxygen&stimulation/CPR x 2-4dy
(R) side hurts arm to knee (not down the arm). No swelling noted. Discomfort getting worse x 2 days.
Patient called today wondering if her Miralax was the same as the PEG in the vaccine she received and would be the reason for her allergy.  She had a goosebump rash all over prior to vaccination and denied any allergies prior to this event.  After vaccination (not certain of time frame) she developed a goosebump, red dot, hot, itchy, spot rash all over legs and arms.  Her dermatologist biopsy confirmed a drug eruption.  She does use an ice pack for relief and was prescribed prednisone.  My final recommendation was to stop taking Miralax and report all of this to primary care MD.  Also, recommended she discuss the second vaccine with both the dermatologist and PCP.  At first patient denied having and allergic type symptoms to Miralax (ex. diarrhea and cramping).  She only divulged having the goosebump rash (not as bad) prior to vaccination at the end of our conversation.
Day following vaccination lat. upper right arm erythema and color. By 04/19/2002, erythema had t'd, no fever, not ill. Was instructed to use ibuprofen (children's) as directed and 1% hydrocortisone